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Abstract
In mice, plasmacytoid dendritic cells (pDC) and natural killer (NK) cells both contribute to re-
sistance to systemic infections with herpes viruses including mouse Cytomegalovirus
(MCMV). pDCs are the major source of type I IFN (IFN-I) during MCMV infection. This re-
sponse requires pDC-intrinsic MyD88-dependent signaling by Toll-Like Receptors 7 and 9.
Provided that they express appropriate recognition receptors such as Ly49H, NK cells can
directly sense and kill MCMV-infected cells. The loss of any one of these responses in-
creases susceptibility to infection. However, the relative importance of these antiviral im-
mune responses and how they are related remain unclear. In humans, while IFN-I
responses are essential, MyD88 is dispensable for antiviral immunity. Hence, a higher re-
dundancy has been proposed in the mechanisms promoting protective immune responses
against systemic infections by herpes viruses during natural infections in humans. It has
been assumed, but not proven, that mice fail to mount protective MyD88-independent IFN-I
responses. In humans, the mechanism that compensates MyD88 deficiency has not been
elucidated. To address these issues, we compared resistance to MCMV infection and im-
mune responses between mouse strains deficient for MyD88, the IFN-I receptor and/or
Ly49H. We show that selective depletion of pDC or genetic deficiencies for MyD88 or TLR9
drastically decreased production of IFN-I, but not the protective antiviral responses. More-
over, MyD88, but not IFN-I receptor, deficiency could largely be compensated by Ly49H-
mediated antiviral NK cell responses. Thus, contrary to the current dogma but consistent
with the situation in humans, we conclude that, in mice, in our experimental settings, MyD88
is redundant for IFN-I responses and overall defense against a systemic herpes virus infec-
tion. Moreover, we identified direct NK cell sensing of infected cells as one mechanism able
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tect MyD88- or IRAK4-deficient patients from viral infections.
Author Summary
Type I interferons (IFN-I) are innate cytokines crucial for vertebrate antiviral defenses.
IFN-I exert antiviral effector functions and orchestrate antiviral immunity. IFN-I are in-
duced early after infection, upon sensing of viral particles or infected cells by immune re-
ceptors. Intracellular Toll-like receptors (TLR) are selectively expressed in specialized
immune cell types such as plasmacytoid dendritic cells (pDC), enabling them to copiously
produce IFN-I upon detection of engulfed viral nucleic acids. pDC or intracellular TLR
have been reported to be crucial for resistance to experimental infections with many virus-
es in mice but dispensable for resistance to natural infections in humans. Our aim was to
investigate this puzzling difference. Mice deficient for TLR activity mounted strong IFN-I
responses despite producing very low IFN-I levels and controlled the infection by a moder-
ate dose of murine cytomegalovirus much better than mice deficient for IFN-I responses.
Deficient TLR responses could be compensated by direct recognition of infected cells by
natural killer cells. Hence, we identified experimental conditions in mice mimicking the
lack of requirement of TLR functions for antiviral defense observed in humans. We used
these experimental models to advance our basic understanding of antiviral immunity in a
way that might help improve treatments for patients.
Introduction
Type I interferons (IFN-I) orchestrate vertebrate antiviral defenses through two complementary
mechanisms [1]. These cytokines induce multiple Interferon Stimulated Genes (ISG) coding for
effector molecules of cell-intrinsic antiviral immunity. IFN-I instruct antiviral innate and adap-
tive immunity, in part by promoting the maturation of dendritic cells (DC) for potent activation
of natural killer (NK) cells and CD8 T lymphocytes. Genetic deficiencies compromising IFN-I
responses dramatically increase susceptibility to viral infections in mice and men [2]. In addition
to IFN-I, type III interferons (IFN-III) also appear critical for antiviral defense, based on the
analysis of mutant mice, and on the strong association between resistance to viral infections and
polymorphisms affecting these genes in humans [1, 3, 4]. IFN-I and IFN-III share the same sig-
naling pathways and downstream target genes. However, while the IFN-I receptor (IFNAR) is
ubiquitously expressed, the receptor for IFN-III is selectively expressed in epithelial cells [1].
The contribution of different cell types and molecular sensors to IFN-I induction during
viral infections is the subject of debate. IFN-I can be induced by two major mechanisms in in-
fected hosts [1]. Potentially all host cell types are equipped with innate immune sensors of en-
dogenous viral replication that can trigger IFN-I production. Certain immune cell types are
also able to sense viral infection in their surroundings and consequently produce high levels of
IFN-I without being infected. This ability is especially strong in the plasmacytoid subset of DC
(pDC). pDC recognize and engulf viral particles or material derived from infected cells. Subse-
quent detection of nucleic acids by toll-like receptors (TLR) 7 and 9 in specialized endosomes
leads to MyD88- and IRAK4-dependent IFN-I induction [5]. On the other hand, while patients
genetically deficient forMYD88 or IRAK4 show enhanced susceptibility to mycobacteria, they
are resistant to most viral infections [6–8]. MyD88 is critical for signaling not only by all TLRs
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except TLR3 but also by the receptors for all members of the interleukin-1 (IL-1) cytokine fam-
ily [9]. Hence, in humans, pDC, TLR7/8/9 and all the IL-1 cytokine family are largely redun-
dant for antiviral defense, in particular with regards to induction of protective IFN-I responses
[8]. In contrast, mice genetically deficient for Tlr7, Tlr9 orMyd88 show enhanced susceptibility
to a broad range of pathogens including many viruses [8]. pDC production of IFN-I has been
proposed to be essential in mice for the control of acute systemic viral infections in particular
with herpes viruses [10–12] or coronaviruses [13]. pDC may also contribute to prevent the es-
tablishment of chronic infections with certain viruses [14–16]. Here, we designed experimental
studies to investigate what could explain this reported discrepancy between humans and mice
for the importance of MyD88 responses in antiviral defense. During viral infections in mice,
the impact of MyD88 inactivation or pDC depletion had only been assessed on the basis of
IFN-I production. Here, we also examined how it affected the induction of protective IFN-I re-
sponses. We also investigated whether NK cell responses could compensate for MyD88 defi-
ciency for host resistance.
We used experimental infection by murine cytomegalovirus (MCMV), a natural pathogen
of mice [17], for which IFN-I responses are critical for protection both in vitro in macrophages
[18–21] and in vivo [22, 23]. pDC sense MCMV infection through TLR7/9 [24–27] and consti-
tute the major source of IFN-I in vivo [10, 24, 28, 29]. However, infected stromal cells have also
been described as potent IFN-I producers in the spleen, 8 hrs after infection [30]. NK cells
sense MCMV infection through their activating receptor Ly49H, allowing them to specifically
recognize and kill infected cells through binding to m157, a viral protein expressed at their sur-
face. pDC depletion prior to infection leads to a dramatic decrease of serum IFN-I levels but
only to a modest and transient increase in viral loads in most organs [5, 10, 24, 29]. In contrast,
either NK cell depletion, or deficiency in endosomal TLR activity, decreases the ability of
C57BL/6 mice to control viral replication and increases morbidity and mortality [24–27, 31]. It
is assumed that the enhanced susceptibility to certain systemic viral infections of mice deficient
for endosomal TLR activity is largely due to their decreased IFN-I production [8, 10–13, 24,
27]. However, whether tissue responses to IFN-I are reduced in these animals has not been ex-
amined. Moreover, other immune functions are dampened or lost in these animals, including
IL-12 production [5] and, in MyD88-deficient mice, responses to all member of the IL-1 cyto-
kine family [9]. Moreover, the respective contributions of IFN-I-, MyD88- and Ly49H-
dependent responses to overall resistance to MCMV infection has not been rigorously investi-
gated in parallel in mice of the same genetic background, deficient for one or more of these re-
sponses. We thus designed a study to rigorously explore howMyD88 genetic deficiency in
mice affects their responses to MCMV infection, in particular their ability to mount strong
type I IFN responses and to resist disease development, for comparison with the analysis previ-
ously published in patients genetically deficient forMYD88 [7]. In both species, MyD88 defi-
ciency does not only affect direct viral sensing by TLRs but also signaling by all IL-1 family
cytokines including IL-18. We also wanted to explore whether the consequences of MyD88 de-
ficiency could be modulated by mutations or polymorphisms in other immune genes, for ex-
ample those encoding NK cell activating receptors. In steady state conditions, in mice, IL-18
has been reported to be crucial for NK cell functional maturation, enabling them to respond to
activation with synthetic stimuli [32]. Hence, using MyD88-deficient animals to examine the
interaction between DC and NK cell direct sensing of infected cells might not seem optimal
since MyD88-deficiency could affect NK cell responses in a cell-intrinsic manner. During
MCMV infection in vivo, contradictory results have been reported regarding the role of IL-18
in the promotion of the proliferation of Ly49H+ NK cells, with no role observed in one study
[33], an absolute requirement reported in a another study [34], and an important contribution
but not an absolute requirement in a third study [35]. In any case, IL-18 has been described as
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a cytokine crucial for IFN-γ production by NK cells in the spleen but not in the liver and ap-
pears to be dispensable for resistance to MCMV infection under conditions where IL-12 and
NK cells are critical [36]. In other words, IL-18 does not seem to be required for NK cell-
dependent protection against primary MCMV infection. CD8 T cell responses are also impor-
tant for immune defense against CMV infection in human and mice [5]. TLR or IL-1 stimula-
tion of DC are considered to be critical for the induction of protective antiviral cellular
adaptive immunity [37, 38]. CD8 T cell responses against MCMV are altered in mice affected
in their MyD88 or NK cell activities [24, 39–42]. However, how NK and MyD88 responses are
integrated in the shaping of antiviral CD8 T cells responses has not been examined.
We used a series of mutant BALB/c mice expressing or not Ly49H, and deficient or not for
MyD88 or for the receptor for IFNAR. We characterized their immune response and overall re-
sistance to MCMV infection. We used BALB/c congenic animals, C.B6-Klra8Cmv1-r/UwaJ
mice referred to as BALB/c-Ly49H+ mice in the manuscript, which carry most of the C57BL/6
NK gene complex, not only limited to Ly49h [43]. Contrary to the situation observed in BALB/
c mice, in BALB/c-Ly49H+ mice NK cells play a major role in the control of an in vitro grown
WTMCMV Smith virus. This protective NK cell activity is almost completely abrogated when
using an in vitro grown MCMV Smith virus strain lacking them157 gene [44]. Here, we com-
pared viral control and mortality between BALB/c and BALB/c-Ly49H+ mice upon infection
with a K181 virus strain lacking them157 gene, Δm157 MCMV [45]. Upon infection with a
moderate dose of salivary gland-extracted Δm157 MCMV, BALB/c-Ly49H+ mice did not con-
trol viral replication more efficiently or survive better than BALB/c animals (S1A–S1C Fig). Al-
together, these observations strongly suggest that most of the differences observed in the
increased resistance to MCMV infection of BALB/c-Ly49H+ mice as compared to BALB/c ani-
mal likely result from the much more efficient recognition of infected cells by their NK cells,
due to the interaction of the Ly49H NK cell activation receptor with the viral m157 protein ex-
pressed at the surface of infected cells. Nevertheless, some contributions for other genes en-
coded in the NK gene complex cannot be totally excluded. We chose to inject MCMV
intraperitoneally because it is the most frequent route of inoculation used with MCMV and be-
cause it rapidly causes a systemic infection, which resolution is thought to more stringently de-
pend of systemic production of IFN-I by pDC than for local infections. Indeed, with several
other viral infections, including infections with the herpesviruses HSV-1 and HSV-2, pDC
were shown to contribute to IFN-I production only under condition of systemic viral spread
and not under conditions where the infections is performed and controlled in epithelia [12,
46]. Moreover, in mice, pDC depletion compromises the control of HSV-1 or HSV-2 only for
systemic but not local infections [12]. Our results demonstrate that, in our experimental set-
tings, MyD88 but not IFN-I responses are largely redundant for control of a systemic herpes
virus infection in mice. This contradicts current thinking but reconciles the requisite of mice
and men for innate antiviral defense. We identify direct recognition of infected cells by NK
cells as one innate immune sensing mechanism able to compensate in part for the loss of
MyD88 activity. Our results also highlight an unexpected ability of low levels of IFN-I to induce
strong cell-intrinsic antiviral immunity in vivo, emphasizing the importance of measuring re-
sponses to, rather than production of, cytokines to assess their physiological role.
Results
pDC or MyD88 deficiency dramatically decreases IFN-I production but
still allows a strong ISG induction during MCMV infection
To assess the contribution of pDC activation and endosomal TLR7/9 triggering to IFN-I re-
sponses during MCMV infection, we analyzed the induction of IFN-I and ISG in the spleen or
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blood of BALB/c mice knocked-out for MyD88 or TLR9, or depleted of pDC through adminis-
tration of the 120G8 mAb directed against Bst2. 120G8 mAb injection dramatically reduced
circulating IFN-I titers and splenic Ifnb1 expression at d1.5 after infection (Fig 1A and 1B).
However, unexpectedly, only a slight impairment was observed in splenic induction of 3 ca-
nonical ISG at d1.5 and 3 after infection (Fig 1B). Consistently, 120G8 mAb injection in BALB/
c mice did not compromise splenic viral control at d6 (S2A and S2B Fig). Because the adminis-
tration of the 120G8 mAb resulted in an efficient and selective, even though not entirely specif-
ic, depletion of pDC during MCMV infection (see materials and methods), we can rigorously
conclude that pDC and their high systemic production of type I IFN are not required for induc-
tion of strong type I IFN responses and relatively efficient control of MCMV infection in our
experimental settings. Similar results were obtained for splenic induction of Ifnb1 and ISG in
BALB/c MyD88-/- and BALB/c TLR9-/- mice (Fig 1B and S2C Fig). In contrast, ISG induction
was completely abrogated in IFNAR-/- animals (Fig 1B). Thus induction of strong IFN-I re-
sponses in the spleen of MCMV infected mice seems not to require pDC, MyD88 or TLR9
functions and can be induced by very low levels of IFN-I.
High IFN-I responses are observed in MCMV-infected mice, irrespective
of pDC activation and IFN-I serum titers
Systemic levels of IFN-I during MCMV infection are controlled by a balance between pDC and
NK cell activation [5]. High systemic IFN-I production not only requires the ability of pDC to
sense viral nucleic acids through functional endosomal TLR, but is also promoted by viral repli-
cation, which is normally limited by NK cell activity. Hence, to generalize our observation that
very low levels of IFN-I production are sufficient to induce strong IFN-I responses, we next
measured pangenomic ISG induction in mice with low serum IFN-I titers (Fig 1C) and splenic
pDC IFN-I expression (S2A and S2D Fig) resulting either from a primary immune deficiency
(MyD88-/- animals) or on the contrary from early control of the virus by NK cells (Ly49H+ ani-
mals). A strong induction of most IFN-I/III genes was observed in BALB/c mice at d1.5 after
MCMV infection. This progressively decreased over time to become undetectable by d6 (Fig
1D). In contrast, hardly any induction of IFN-I/III genes was seen in BALB/c-Ly49H+ and
BALB/c-Ly49H+ MyD88-/- animals, and only a weaker and delayed induction was observed in
BALB/c MyD88-/- mice (Fig 1D). However, strikingly, a very strong ISG induction was ob-
served in all mouse strains, already at d1.5 after MCMV infection. This was maintained until
d3 in all mouse strains and was still strong at d6 in BALB/c and BALB/c MyD88-/- mice (Fig 1E
and S2E–S2G Fig). Thus, induction of strong IFN-I responses in the spleen of MCMV infected
mice does not require pDC, MyD88 and TLR9 function and can be induced optimally under
conditions where IFN-I/III are undetectable not only in the circulation but also in the spleen
both at protein and mRNA levels. Hence, contrary to the commonly accepted dogma, pDC,
MyD88 and TLR9 are dispensable in mice for induction of strong IFN-I responses against sys-
temic infection with a herpes virus, in our experimental settings.
IFN-I responses are essential to promote resistance to MCMV infection
irrespective of Ly49H expression and confer a significant level of
protection even in MyD88-/- deficient animals
We next examined to what extent IFN-I responses are required for defense against MCMV
under our experimental conditions. We tested susceptibility to MCMV infection of 6 different
mouse strains, with deficiencies in either IFNAR or MyD88, and expressing or not Ly49H (Fig
2), or selectively depleted for pDC (S3 Fig). We infected these animals with serial doses of
MCMV, to define the LD50 inoculum at which 50% of the animals were killed (Fig 2A). As
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Fig 1. pDC or MyD88 deficiency impairs IFN-I production but not splenic IFN-I responses and virus control. Control (Rat IgG), pDC-depleted (αBST2)
or untreated BALB/c mice and untreated BALB/c, BALB/c MyD88-/-, BALB/c IFNAR-/- and BALB/c TLR9-/- mice were infected with 2.5 x 103 pfu MCMV or left
uninfected (NI). (A) IFN-α serum titers were measured at d1.5 post-infection by ELISA. Results (mean±SEM) are shown from one experiment representative
of 3 independent ones. (B) RT-PCR analysis of the expression of selected genes in the spleen at d1.5 or 3 post-infection. Data are normalized to mean
expression of d1.5 BALB/c mice (100% reference level). Results (mean±SEM) are shown from 2 pooled independent experiments, each with 2 to 3 mice per
group. (C) Serum IFN-α levels were measured at d1.5 post-infection by ELISA in BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c and BALB/c MyD88-/-
mice. Results (mean±SEM) are shown from one experiment representative of 3 independent ones, each with 3 mice per group. BLD: below limit of detection.
(D-E) Microarray analyses were performed on total mRNA extracted from spleen at d0, 1.5, 2, 3 and 6 post-infection. Heatmaps show the relative expression
value for IFN-I/III genes (D) and for 25 ISG (E). The expression pattern of ISG is examined globally in S2E–S2G Fig. Results shown are from 2 pooled
independent experiments, each with 1 to 3 mice per group.
doi:10.1371/journal.ppat.1004897.g001
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expected, BALB/c-Ly49H+ mice were the most resistant to infection. BALB/c IFNAR-/- and
BALB/c-Ly49H+ IFNAR-/- mice were the most susceptible, with an LD50 more than 50 times
lower than that of BALB/c-Ly49H+ animals. Thus, IFN-I responses are critical for defense
against MCMV infection even in mice bearing the Ly49H activating receptor allowing direct
sensing of infected cells by NK cells. Strikingly, BALB/c-Ly49H+ MyD88-/- and BALB/c
MyD88-/- mice harbored clearly higher LD50 than IFNAR
-/- animals. Hence, MyD88-/- mice
were significantly more resistant than IFNAR-/- animals, despite their low to undetectable pro-
duction of IFN-I. In addition, pDC depletion did not increase the susceptibility of BALB/c
mice after infection with the LD50 (S3 Fig). Thus, the induction of IFN-I responses to levels al-
lowing a significant control of MCMV infection does not require MyD88 and pDC functions.
Contrary to IFNAR deficiency, MyD88 deficiency can be compensated at
least in part by direct sensing of infected cells by NK cells
The sensitivity to MCMV infection conferred by IFNAR deficiency was independent of the ex-
pression of Ly49H. This was not the case for MyD88 deficiency. BALB/c-Ly49H+ MyD88-/-
mice were clearly more resistant than BALB/c MyD88-/- mice (Fig 2A). Conversely, the sensi-
tivity to MCMV infection associated with Ly49H deficiency was aggravated by MyD88 defi-
ciency, since BALB/c mice were more resistant than BALB/c MyD88-/- mice (Fig 2A). BALB/c
and BALB/c-Ly49H+ MyD88-/- mice exhibited similar LD50. Hence, the deficiency in TLR-
mediated MCMV sensing by DC and in responses to IL-1 cytokine family can be compensated
at least in part by direct sensing of infected cells by NK cells and vice versa. Indeed, under con-
ditions of infection with a moderate MCMV dose, below the LD50 of BALB/c MyD88
-/- mice,
Fig 2. IFN-I responses are essential but MyD88 and Ly49H partly redundant to protect against MCMV infection. (A) Survival of mice at d21 post-
infection (Y-axis) as a function of the doses of MCMV inoculum (X-axis). Indicated mice were infected with between 1.6x103 and 7x104 PFU of MCMV, with
overlaps for several doses between strains of mice, and their survival was followed for 21d. Data is shown as percentage of survival. In total, 8 different doses
were tested in 9 different experiments in order to determine the susceptibility of each mouse strain, with 2 to 4 mouse strains simultaneously studied in each
experiment. Data was derived from the following numbers of mice and tested doses of MCMV inoculum: BALB/c-Ly49H+: 24 mice for 4 doses; BALB/c-
Ly49H+ MyD88-/-: 37 mice for 6 doses; BALB/c-Ly49H+ IFNAR-/-: 8 mice for 2 doses; BALB/c: 43 mice for 5 doses; BALB/c MyD88-/-: 15 mice for 4 doses;
BALB/c IFNAR-/-: 6 mice for 2 doses. The median lethal dose that causes 50% of lethality in each mouse strain (LD50) was calculated from the graph as the
dose on the X-axis that corresponds to 50%mortality on the Y-axis as represented by the horizontal dotted line labeled “LD50 calculation”. LD50 BALB/c-
Ly49H+:105 pfu/mouse; LD50 BALB/c-Ly49H+ MyD88-/-: 3.3x104 pfu; LD50 BALB/c-Ly49H+ IFNAR-/-: 2x103 pfu; LD50 BALB/c: 2.2x104 pfu; LD50 BALB/c
MyD88-/-: 8x103 pfu; LD50 BALB/c IFNAR
-/-: 2x103 pfu. (B) Splenic viral titers were measured at d1.5, 3 and 6 post-infection. Data (mean±SEM) are shown
from 2 to 4 pooled independent experiments, each with 2 to 3 mice per group.
doi:10.1371/journal.ppat.1004897.g002
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control of viral replication was significantly less efficient in these animals than in the three
other mouse strains examined (Fig 2B). NK cell activation during MCMV infection depends
on IL-12, IL-18 and IL-15 [5, 35]. The induction and/or activity of IL-12 and IL-18 are both
strongly decreased in MyD88-/- C57BL/6 mice. This correlates with a significant impairment of
NK cell responses under conditions of high viral inoculum [5]. In contrast, here, the survival
and viral titers observed suggested that functional antiviral NK cell responses were induced in
BALB/c-Ly49H+ MyD88-/- mice. Thus, we examined NK cell functions in BALB/c mice defi-
cient or competent for MyD88, and expressing or not Ly49H (Fig 3). At d3 after MCMV infec-
tion, the Ly49H+ NK cells from BALB/c-Ly49H+ MyD88-/- mice were clearly activated
although to a significantly lesser extent than in BALB/c-Ly49H+ animals (Fig 3A–3D and S4A
and S4C Fig). Diminished IL-12 and type I IFN production by DC as well as cell-intrinsic loss
Fig 3. MyD88 deficiency does not completely abrogate NK cell-mediated protection. (A-D) Ly49H+ NK cell activation in BALB/c-Ly49H+, BALB/c-
Ly49H+ MyD88-/- and BALB/c-Ly49H+ IFNAR-/- mice at d0, 3 and 6 post infection. Proliferation was assessed by Ki67 expression (A). Antiviral effector
functions were assessed by intracellular staining for IFN-γ (B) and Granzyme B (C-D). (E) Impact of NK cell depletion on viral replication in the spleen of
BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/- and BALB/c-Ly49H+ IFNAR-/- mice. Mice were depleted of NK cells and splenic viral titers were measured 5 or 6d
post infection. (F-I) Ly49H- NK cell activation in BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88, BALB/c-Ly49H+ IFNAR-/-, BALB/c, BALB/c MyD88-/- and BALB/c
IFNAR-/- mice. Data (mean±SEM) are shown from 3 pooled independent experiments each with 3 mice per group.
doi:10.1371/journal.ppat.1004897.g003
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of IL-18 signaling could all have contributed to the decrease in NK cell proliferation, produc-
tion of IFN-gamma and expression of Granzyme B observed in MyD88-/- mice, according to
previous reports which analyzed the contribution of these different responses during MCMV
infection [23–26, 35, 36, 47, 48]. In any case, at d6 after MCMV infection, the activation of
Ly49H+ NK cells was higher in BALB/c-Ly49H+ MyD88-/- mice as compared to BALB/c-
Ly49H+ animals (Fig 3A–3D). Moreover, NK cell depletion led to a significant increase in viral
replication not only in BALB/c-Ly49H+ mice but also in BALB/c-Ly49H+ MyD88-/- animals
(Fig 3E and S4D Fig). Thus, NK cells can be sufficiently activated so as to contribute signifi-
cantly to the control of MCMV infection despite a primary immune deficiency that abrogates
viral sensing by DC through TLR7/9, as well as the responses to IL-18 and all other IL-1 family
cytokines, provided that the NK cells can directly recognize virally infected cells through trig-
gering of a dedicated NK cell activating receptor. Ly49H+ NK cells from BALB/c-Ly49H+
IFNAR-/- mice were significantly activated at d3 and d6 post infection (Fig 3A–3D), to levels
similar to those observed in BALB/c-Ly49H+ MyD88-/- mice. However, in contrast to the situa-
tion in the latter animals, in BALB/c-Ly49H+ IFNAR-/- mice, viral replication did not appear to
be curtailed by NK cell activity, since it was already very high in untreated mice and was not in-
creased further upon NK cell depletion (Fig 3E). These results suggest that Ly49H+ NK cells
are similarly activated in BALB/c-Ly49H+ IFNAR-/- and BALB/c-Ly49H+ MyD88-/- mice but
fail to control viral replication in the former because the absence of IFN-I response allows fast
and widespread virus replication overwhelming the antiviral functions of Ly49H+ NK cell.
Thus, MyD88 but not IFNAR deficiency can be compensated at least in part by direct sensing
of infected cells by NK cells in our experimental model of systemic MCMV infection.
NK cell activation in MyD88-/- mice does not require cell-intrinsic Ly49H
signals but likely relies on residual IL-12 responses
A strong activation of Ly49H- NK cells was observed in all infected mice (Fig 3F–3I and S4A
and S4B Fig). Hence, NK cell activation in MyD88-/- mice did not require cell-intrinsic Ly49H
signals. IL-12 and IL-18 production were decreased in MCMV-infected BALB/c MyD88-/- and
BALB/c-Ly49H+ MyD88-/- mice (S4E Fig). However, similarly to what happened with the
IFN-I response, IL-12/18 stimulated genes were strongly induced in infected MyD88-/- mice
(S4F and S4G Fig). Hence, persistence of NK cell activation in MyD88-/- mice likely resulted
from residual IL-12 production and subsequent IL-12-dependent responses.
The combined deficiency for Ly49H and MyD88 prevents the expansion
of antiviral CD8 T cells
We next investigated the functions and numbers of antiviral CD8 T cells in the different mouse
strains under study. Contrary to our expectations, the in vivo cytotoxic activity of anti-MCMV
CD8 T cells was similar in the four mouse strains examined at d6 after infection (Fig 4A and
S5A Fig). The CD8 T cells from Ly49H-/-MyD88-/- mice even exhibited a significantly stronger
expression of IFN-γ and Granzyme B directly ex vivo without any restimulation (Fig 4A and
S5B Fig). Moreover, depletion of CD8 T cells led to a significant increase of viral replication
both in BALB/c and BALB/c MyD88-/- animals (Fig 4B and S5B Fig). Thus, during MCMV in-
fection, CD8 T cells are hyperactivated in BALB/c MyD88-/- animals and contribute to the con-
trol of viral replication. Hyperactivated CD8 T cell responses can contribute to liver
immunopathology and death during MCMV infection [49]. However, CD8 T cell depletion led
to a higher mortality of BALB/c MyD88-/- mice (Fig 4C), ruling out a deleterious role of CD8 T
cells in our experimental settings. Upon infection, there was a strong and significant increase
in the numbers of total and anti-MCMV CD8 T cells in all of the three mouse strains
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expressing MyD88 and/or Ly49H, but not in BALB/c MyD88-/-animals (Fig 4D). Hence, since
the efficiency of viral control in vivo by CD8 T cells depends on the local effector-to-target
ratio in infected tissues [50], the enhanced susceptibility of BALB/c MyD88-/- mice to MCMV
infection likely resulted in part from their failure to expand their antiviral CD8 T cells. As com-
pared to the other mouse strains, the BALB/c MyD88-/- mice exhibited a significant increase in
their splenic expression of genes associated with CD8 T cell exhaustion or with fibrosis and a
decrease in the expression of the gene signature of red pulp macrophages (S5C and S5D Fig).
Fig 4. Impact of MyD88 or Ly49H deficiencies on antiviral CD8 T cell responses. (A-C) Analysis of antiviral CD8 T cell effector functions. (A) In vivo
cytotoxicity, ex vivo IFN-γ production and Granzyme B expression by splenic CD8 T cells from BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c and
BALB/c MyD88-/- mice at d0 and 6 post infection. Data (mean ± SEM) are shown from 3 pooled independent experiments each with 2 or 3 mice per group.
(B-C) Impact of CD8 T cell depletion on disease in BALB/c and BALB/c MyD88-/- mice. Mice were depleted of CD8 T cells and infected with 2.5x103 pfu
MCMV (B) or with 8x103 pfu MCMV (C). Splenic viral titers were measured at d6 post infection (B) or mortality was monitored daily (C). For B, data (mean
±SEM) are represented from 2 pooled independent experiments each with 2 to 4 mice per group. For C, data show the percent survival from 2 pooled
independent experiments each with 3 to 5 mice per group, n represents the total number of mice per group. (D) Enumeration of total (left panel) and anti-IE-1
(right panel) CD8 T cells in the spleens of d5 MCMV-infected mice. Results (mean±SEM) are shown from 4 pooled independent experiments each with 3
mice per group. (E) Immunohistological analysis of tissue damage to the spleen in d4 MCMV infected mice. Mice were infected with 104 pfu MCMV. Spleen
were harvested at d4 and stained to evaluate the integrity of the T cell zone as assessed by examining its marginal zone boundary (CD169) and its T cell
(CD3) and B cell (B220) zones. Results are shown for one representative mouse per experimental group from 3 independent experiments each with 3 mice
per group.
doi:10.1371/journal.ppat.1004897.g004
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This is consistent with the early and strong depletion of those cells previously reported in mice
lacking efficient antiviral NK cell responses and infected with a high dose of MCMV [51]. At
d4 post infection, BALB/c MyD88-/- and BALB/c IFNAR-/- mice also harbored a marked dis-
ruption of their spleen architecture (Fig 4E). Altogether, these observations suggest that early,
strong and irreversible damage is caused to secondary lymphoid organs upon infection in
Ly49H-/-MyD88-/-animals. This possibly is a consequence of persistently high levels of viral
replication that cause a loss of the support function of these organs for all T cells and favor ex-
haustion of antiviral CD8 T cells. The early and profound loss of splenic red pulp macrophages
and stromal cells occurring in BALB/c MyD88-/-animals, as witnessed by microarray analysis,
likely contribute significantly to the loss of the specific micro-anatomical niches required for
sustaining high numbers of antiviral CD8 T cells. Thus, either efficient antiviral NK cell activity
or MyD88 functions are necessary to promote antiviral CD8 T cell responses while simulta-
neous failure of both responses strongly compromises antiviral adaptive immunity.
Discussion
IFN-I responses are essential for defense against most viral infections in mice and men [2, 52–
54]. However, it has been claimed that the requirements for pDC and endosomal TLR in IFN-I
production differ fundamentally during natural infections of men and experimental challenges
of laboratory mice [8], since IRAK4 or MyD88 genetic deficiencies only increase susceptibility
to viruses in mice. However, whether IFN-I responses are impaired in infected MyD88-/- mice
and whether this contributes to their enhanced susceptibility to viral infections had not previ-
ously been rigorously examined. Moreover, it is unknown whether other immune responses
could compensate for MyD88 deficiency during resistance to viral infections in mice as must
occur in humans.
Our results show that IFN-I responses are critical for defense against MCMV infection in
mice. However, in our experimental settings, pDC and MyD88 are not required for the induc-
tion of protective IFN-I responses while they are crucial for high systemic production of these
cytokines. Contrary to expectations [8, 11, 12], in mice, high systemic production of IFN-I re-
sulting from endosomal sensing of viruses by pDC is dispensable for relatively efficient intrin-
sic, innate and adaptive immune responses to our model of systemic infection by a herpes
virus. This observation is consistent with the redundancy of pDC and TLR7/9 functions but
not IFN-I responses for antiviral defense in humans [2, 6–8, 53, 54]. Moreover, even if mice de-
ficient for MyD88 are more susceptible than wild-type animals to MCMV infection, this can be
compensated by other modalities of innate sensing of the infection, namely in our experimental
set-up by direct NK cell recognition of infected cells. Hence, while IFN-I, IFN-γ and cytotoxic
responses are all necessary for immune defenses against MCMV infection and most other ex-
perimental viral infections in mice, access to these functions can be promoted by a number of
complementary and/or partly redundant pathways. These include the triggering of different in-
nate immune recognition receptors and the mobilization of distinct cell types with overlapping
antiviral activities (Fig 5). Indeed, Ly49H+ NK cells can promote early control of MCMV repli-
cation in the absence of CD8 T cells [55, 56] and vice versa [57, 58], likely because they exert
partly overlapping functions including IFN-γ production and cytotoxicity [59–62] (Fig 5).
However, in RAG-deficient C57BL/6 mice lacking B and T cell responses, immune escape vari-
ants mutated for m157 are selected over time and ultimately cause the death of the mice after
several weeks [55, 56]. Hence, context-dependent redundancies in innate and adaptive antiviral
immune responses likely contribute to the robustness of host defenses under physiological con-
ditions despite the immune evasion strategies developed by many viruses, as illustrated also by
the demonstration of redundancies and complementarities between NK cells, CD8 T cells and
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Fig 5. Model of redundancies and complementarities betweenmolecular sensors and cell types for mounting the IFN-I, IFN-γ and cytotoxic
cellular immune responses which are necessary for control of MCMV infection. Based on our own data as well as on many other studies published
previously, we propose a model whereby IFN-I, IFN-γ and cytotoxic responses are all necessary for immune defenses against MCMV infection (red lines and
text), but access to these functions can be promoted by a number of partly redundant and/or complementary pathways (arrows converging towards a
number). IFN-I, IFN-γ and cytotoxic cellular immune responses are critical for control of viral replication, prevention of excessive tissue damage and overall
resistance of the host in terms of morbidity and mortality. Several cell types and pathways can lead to IFN-I production. Early after intra-peritoneal injection,
MCMV infects stromal cells and other cell types, inducing an IFN-I production by those cells independently of MyD88 and TLRs. In addition, viral particles or
material derived from infected cells can be engulfed by cDC and pDC to promote their production of high levels of IFN-I or other cytokines upon triggering of
the TLR7/9-to-MyD88 signaling cascade. In our experimental settings, MyD88/TLR9 responses of DC and MyD88-independent responses of infected cells
are redundant for the induction of strong IFN-I responses, even though only very low to undetectable levels of IFN-I are produced in the absence of MyD88
responses (❶). In parallel, NK cells and CD8 T cells are able to produce IFN-γ and to specifically recognize and kill MCMV infected cells, via the activation
receptor Ly49H or via their TCR, respectively. Cell-mediated immune control of viral replication can thus be performed by both NK and CD8 T cells which can
largely compensate one another for this function (❷). However, the antiviral functions of NK and CD8 T cells are not strictly redundant but partly
complementary, since, for example, the absence of CD8 T cell responses might increase the risk of selection of viral mutants able to escape NK cell control.
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CD4 T cells in the prevention of MCMV reactivation in latently infected mice lacking humoral
immunity [63]. It is likely that other innate immune effector cells contribute to context-
dependent redundancies in antiviral defense mechanisms in mice, including NK T cells [64–
68] or γδ T cells [69, 70]. Similarly, the absence of overtly increased susceptibility to viruses in
patients genetically deficient for endosomal TLR activity due to loss-of-function mutations in
MYD88 or IRKA4 likely results from their preserved ability to mount protective intrinsic and
innate immune responses that efficiently control primary infections. These involve not only
IFN-I responses but also innate cytotoxic responses by NK, NK T or γδ T cells [71–73], before
adaptive immunity induction. However, it is possible that pDC and MyD88 are necessary for
efficient host defense under specific conditions of viral infections, including during herpesvirus
infections consecutive to bone marrow transplantation where adaptive immunity and some in-
nate immune responses are suppressed and the conditions of viral replication may be analo-
gous to a high dose challenge.
Our study demonstrates that even undetectably low levels of IFN-I/III are sufficient to in-
duce a strong and widespread expression of genes involved in cell-intrinsic antiviral immunity
during a systemic viral infection, including in MyD88-/- mice. This observation is consistent
with a recent report showing that strongly increasing IFN-I production by pDC during
MCMV infection, while preserving other antiviral immune responses, does not improve con-
trol of viral replication [74]. On the contrary, high systemic IFN-I production by pDC might
even delay the induction of antiviral adaptive immunity due to negative effects on the DC and
CD8 T cell compartments [39, 75]. Hence, delivery of small amounts of IFN-I in a tightly con-
trolled spatio-temporal manner could be a better way to treat certain viral infections or cancers
than administration of high systemic doses of cytokines. The latter treatment may not induce
better cell-intrinsic immunity but rather induce systemic responses associated with severe side
effects [1]. In addition, given current technological limits to cytokine detection, our results sug-
gest that to investigate whether a cytokine plays a physiological role in a disease, one should
quantitate the effect of abrogating cytokine-mediated signaling on disease evolution, and func-
tionally assess how perturbing cytokine activity affects disease outcome, rather than only titrat-
ing cytokine concentration.
One may wonder why infected hosts produce high systemic levels of IFN-I if very low to un-
detectable levels of these cytokines are sufficient to induce a strong expression of ISG and their
downstream protective antiviral functions. One possibility is that high systemic production of
IFN-I by spleen pDC in the absence of protective NK cell responses is necessary to promote de-
fense or homeostasis of distant organs. It was recently published that elevated levels of IFN-I
has systemic effects which promote epithelial turnover and wound repair [76]. However, since
MyD88-deficient mice harbor only a mild increase in susceptibility to MCMV infection as
compared to IFNAR-deficient mice, these types of systemic IFN-I responses might be rather
required to prevent concomitant heterologous infections or for defense against viruses able to
cause chronic infections, by allowing a systemic state of pathogen alert with induction of pro-
tective responses in all tissues. Indeed, a similar role was recently reported for IFN-γ produc-
tion by tissue-resident memory CD8 T cells, whereby it induced tissue-wide responses able to
protect the skin against viral variants able to escape adaptive immunity or against heterologous
infections [77, 78].
MyD88 responses can promote the activation of NK and CD8 T cells via TLR-dependent activation of myeloid cells and/or through cell-intrinsic effects.
However, MyD88 responses are not necessary for this function in mice expressing NK cell activation receptors able to directly sense MCMV-infected cells. In
these mice, in addition to IFN-I production, MyD88-independent responses from infected cells might provide the other beneficial inflammatory signals
necessary for this function (❸). Functional redundancies might also exist between MyD88 responses and NK cell activity for prevention of excessive damage
to lymphoid tissues (❹), in order to preserve their micro-anatomical niches supporting the proliferation and survival of CD8 T cells.
doi:10.1371/journal.ppat.1004897.g005
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In d6 infected BALB/c-Ly49H+ MyD88-/- mice, not only Ly49H+ but also Ly49H- NK cells
are significantly more activated than in BALB/c-Ly49H+ mice. NK cells are also significantly
activated in infected animals deficient in Ly49H and MyD88 signaling. Hence, NK cells do not
require direct sensing of infected cells for their activation, even at late time points after infec-
tion. Rather Ly49H protects mice against MCMV by allowing cytokine-activated NK cells to
specifically recognize and kill infected cells. The mechanisms promoting NK cell activation in
MyD88-/- mice merit further study. IL-12 and IL-18 play important roles in this process in wild
type animals [35, 36, 47]. The analysis of the expression pattern of target genes of these cyto-
kines in the spleen of infected mice showed that a significant and sustained induction of cyto-
kine responses are still observed in MyD88-/- animals despite a dramatic decrease in the
expression of the cytokines themselves. Hence, similarly to IFN-I, IL-12 requires MyD88 for
high level production but not for functional induction of NK cell activation.
Our result showed that NK cell sensing and killing of infected cells can compensate MyD88
but not IFNAR deficiency for the control of systemic MCMV infection in BALB/c mice. In
contrast, others have reported that IFN-I responses are not required for NK cell activation and
antiviral activity in C57BL/6 mice [42, 79]. This might be due in part to differences between
C57BL/6 and BALB/c mice. Alternatively, this might be due to differences between virus
strains. In the other studies, relatively low inoculum doses of in vitro produced viruses were
used. Viruses deriving from the pSM3fr parental strain are highly attenuated in vivo due to a
mutation in the viral MCK-2 chemokine [80]. Under these experimental settings, Ly49H+ NK
cell responses were shown to completely or moderately compensate deficient IFN-I responses
to promote control of viral replication. Further, NK cell activity was reported to be dispensable
for late (d7) control of viral replication in C57BL/6 mice competent for IFN-I responses in con-
trast to our observations using BALB/c-Ly49H+ mice infected with moderate doses of salivary
gland virus. The morbidity and mortality associated with the infections was not documented
[42, 79]. Hence, it is possible that the previously reported compensation between IFNAR defi-
ciency and NK cell activity resulted in part from the use of highly attenuated conditions of in-
fection allowing clearance of MCMV and survival even in mice deficient for both IFNAR and
Ly49H.
In our study, the higher susceptibility to MCMV of BALB/c MyD88-/- mice as compared to
BALB/c-Ly49H+ MyD88-/- or BALB/c mice was associated with a dramatic decrease in the
number of antiviral and total CD8 T cells in the spleen. BALB/c MyD88-/- mice harbor a strik-
ing disruption of their spleen architecture as early as d4 after infection. Microarray analyses
showed a strong induction of genes associated with fibrosis and a downregulation of the red
pulp macrophage transcriptomic signature at d6 post-infection in the spleen of BALB/c
MyD88-/- animals. Hence, in the absence of efficient antiviral NK cell responses, MyD88 re-
sponses are required to protect the secondary lymphoid organs from extensive tissue damage.
This includes preventing the loss of cell types and micro-anatomical structures necessary to
support protective antiviral immune adaptive responses.
In summary, our study shows that MyD88 responses are dispensable for the induction of
protective IFN-I responses against a systemic herpesvirus infection in mice. We show that the
enhanced susceptibility of MyD88-deficient mice to MCMV infection is not attributable to loss
of IFN-I responses, to decreased NK cell activation or to compromised CD8 T cell priming.
Rather, it results from severe tissue damage to the spleen leading to a failure to sufficiently am-
plify the compartment of effector antiviral CD8 T cells. Moreover, we show that direct recogni-
tion and sensing of virus-infected cells by NK cells can compensate for MyD88- but not
IFNAR-deficiency and promote resistance to a systemic MCMV infection in our experimental
settings. These results challenge our current understanding of the requirements for the induc-
tion of protective responses to systemic viral infections in mice, in particular the role of pDC
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and endosomal TLR7/9 [8, 10–12, 24–27]. These results are consistent with the conclusions
drawn from the studies of human patients suffering from primary immunodeficiencies [2, 6–8,
53, 54]. Hence, immune responses might not differ between mice and men as much as is some-
times suggested. Rather, it is important to define experimental settings in mice that best reflect
clinical observations in humans, in order to take advantage of this versatile animal model to ad-
vance basic immunological knowledge in a way that might benefit human health [81]. Early
disruption of lymphoid organ architecture during human immunodeficiency virus infection
has been proposed as an important cause for the failure of the host to control viral replication
and for disease development [82]. Understanding the mechanisms leading to the disruption of
the architecture of lymphoid organs early during viral infections in mice and how MyD88 or
NK cell responses can prevent this process could open novel avenues to treat viral infections
in humans.
Materials and Methods
Ethics statement
The animal care and use protocols (ID no. 11-09/09/2011) were designed in accordance with
national and international laws for laboratory animal welfare and experimentation (EEC
Council Directive 2010/63/EU, September 2010), and approved by the Marseille Ethical Com-
mittee for Animal Experimentation (registered by the Comité National de Réflexion Ethique
sur l’Expérimentation Animale under no. 14).
Mice and in vivo treatments
8 to 12 week old mice of different strains were used for experiments (see supplemental materi-
als and methods in S1 File). Animals were bred under pathogen-free conditions at CIML. In-
fections were initiated at d0 by i.p. injection of 2.5 x 103 pfu salivary gland-extracted MCMV
K181 v70 [23, 49] or Δm157 [45] strains (third and second in vivo passages, respectively), un-
less specified otherwise. pDC, NK cells or CD8 T cells were depleted in vivo by intraperitoneal
delivery of 500μg anti-Bst2 (120G8) mAb, 100μg anti-NK1.1 mAb or 150μg anti-CD8βmAb.
Antibodies were injected on d-1 before MCMV infection, followed by injections on d1, 3 and 5
for NK cell and pDC depletion, and on d2 and 7 for CD8 T cell depletion. Control mice were
treated with Rat IgG. Cell depletion efficiency was assessed by flow cytometry as detailed in S1
File. Bst2 expression was increased on B cells, NK cells and cDC in infected mice. However,
even under these conditions, the levels of Bst2 expressed by these cells were much lower than
that observed on pDC. No depletion of B cells, T cells and NK cells was observed in our experi-
mental conditions, although we cannot completely exclude that a very small fraction of some
of these cell types was affected due to a higher expression of Bst2, for example plasmocytes.
However, the numbers of cDC in infected mice treated with anti-Bst2 antibody was half that of
infected animals treated with isotype control (S6 Fig).
Spleen preparation and flow cytometry analysis
Spleen leukocyte suspensions were prepared using DNAse I and collagenase D [23], stained as
detailed in S1 File, and acquired on a FACSCanto II Flow Cytometer (BD Bioscience).
mRNA preparation, real-time PCR experiments, quantification of viral
titers and microarray experiments
Pieces of spleen were harvested and stabilized overnight in RNAlater solution (Qiagen). High-
quality total RNA was prepared and used for qRT-PCR or microarrays as previously described
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[23]. Relative gene expression was calculated with the ΔΔCt method using Hprt as housekeep-
ing gene for normalization. Viral titers were measured as absolute levels of expression of the
Ie1 gene [23]. Microarray analyses were performed as previously described [23]. Gene set com-
positions are given in S1 Table. Data have been deposited in the GEO database under reference
GSE62729.
Quantification of serum IFN-α levels
Serum IFN-α2/α4 levels were determined by ELISA (eBioscience) according to the
manufacturer’s instructions.
In vivo cytotoxicity assay
Antigen-specific CD8 T cell–mediated in vivo cytotoxicity was assayed as described [83].
Enumeration of, and effector molecule expression by, antiviral CD8 T
cells
Splenic lymphocytes from mice infected with MCMV were isolated at d6 post infection and
CD8 T cells were analyzed for H-2L(d)/IE-1(168YPHFMPTNL176) binding and intracellular
IFN-γ or Granzyme B expression.
Morbidity and mortality
Infected mice were monitored daily for signs of morbidity (weight loss, piloerection, hunched
posture and lethargy). Imminent death was defined as loss of 20% initial body weight or devel-
opment of severe lethargy (unresponsiveness to touch) established in a preliminary experiment
using death as the endpoint.
Histology
Spleen section were prepared, stained and imaged as previously described [28] and detailed in
S1 File.
Statistical analyses
Statistical analyses were performed using a nonparametric Mann-Whitney test performed with
Prism 6 (GraphPad Software) for all experiments except survival analyses where a Mantel-Cox
test was used. ns, non significant (p> 0.05); p< 0.05; p< 0.01; p< 10–3.
Supporting Information
S1 Fig. Mortality and viral loads in BALB/c and BALB/c-Ly49H+ mice infected with a
Δm157 strain of K181 MCMV.Mice were infected with 2.2x104 pfu of salivary gland-ex-
tracted Δm157 K181 MCMV. (A) This inoculum dose was chosen as close to the LD50 for
BALB/c mice, as determined upon in vivo titration of the virus in this mouse strain. The viral
inoculums used for the titration are indicated on the survival curve. Data are from 1 experi-
ment with 5 mice per group. (B) Mortality was monitored daily; n represents the number of
mice per group. (C) Splenic viral loads at d3 post infection are shown. Dashed line represents
the limit of detection. Data (mean±SEM) are represented from 1 experiment with 4 or 5 mice
per group.
(PDF)
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S2 Fig. Absence of IFN-I production by pDCs does not strongly compromise IFN-I re-
sponses and MCMV control. (A) Verification of pDC depletion efficiency and analysis of
IFN-β expression in pDCs. Data are shown for one representative mouse for each experimental
group. Three independent experiments each with 3 mice per group were performed. Splenic
pDCs were gated as CD3ε-CD19-NKp46-CD11cintSiglecH+ cells. (Top) The frequency of pDCs
is shown in an uninfected and untreated animal, and at d1.5 after infection in one infected con-
trol mouse treated with rat IgG versus in one animal depleted of pDCs by in vivo administra-
tion of α120G8 antibodies. (Bottom) The frequency of pDCs expressing IFN-β directly ex vivo
without any re-stimulation is shown in an uninfected animal, and at d1.5 after infection in one
infected animal for each of the four mouse strains studied, BALB/c-Ly49H+, BALB/c-Ly49H+
MyD88-/-, BALB/c and BALB/c MyD88-/- mice. (B) Impact of pDC depletion on splenic viral
loads at d6 post infection in BALB/c mice. Dashed line represents the limit of detection. Data
(mean±SEM) are represented from 2 pooled independent experiments each with 3 mice per
group. (C) Splenic viral loads at d1.5 post infection with 2.5x103 pfu MCMV in BALB/c and
BALB/c TLR9-/- mice. Dashed line represents the limit of detection. Data (mean±SEM) are rep-
resented from 1 experiment. (D) Frequency of IFN-β+ cells within splenic pDCs of BALB/c-
Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c, BALB/c MyD88-/- and BALB/c TLR9-/- mice at
d0 and d1.5 post infection. Results (mean±SEM) are represented from one experiment repre-
sentative of two independent ones, each with 3 mice per group. (E-F) Gene set enrichment
analysis (GSEA) results for examining enrichment of ISG expression in pairwise comparisons
between d0 and d1.5 after infection in BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c
and BALB/c MyD88-/- mice. (E) Examples of raw GSEA results classically represented as en-
richment plots. Each bar under the curves corresponds to the projection of one of the 1,648
ISG ProbeSets on the red-to-blue gradient representing all the 35,556 ProbeSets from the gene
chip ranked from high expression at d1.5 to high expression at day 0. The more the GeneSet is
differentially expressed between conditions, the more the bar code is shifted to one extremity.
This is measured by two parameters. The normalized enrichment score (NES) represents the
number and differential expression intensity of the genes enriched. The false discovery rate
(FDR) statistical value (q) represents the likelihood that the enrichment of the GeneSet repre-
sents a false-positive finding (e.g., if q = 0.25, a similar enrichment is found in 25% of the ran-
dom GeneSets used as controls). The absolute NES values vary between 1 (no enrichment) and
5 (maximal enrichment possible). The enrichment is considered significant for absolute NES
values> 1 with an associated q value< 0.25. The result from each enrichment plot can be syn-
thesized as a dot, bigger and darker for stronger and more significant enrichment, in a color
matching that of the condition in which the GeneSet was enriched (blue for uninfected mice
and red for infected mice). (F) Summary of GSEA results for all mouse strains and all time
points after infection examined. (G) The heatmap shows the relative expression value for 100
ISG. Results shown are from the same 2 pooled independent experiments than in Fig 1D and
1E, each with 1 to 3 mice per group.
(PDF)
S3 Fig. Impact of pDC depletion on mortality upon MCMV infection. BALB/c mice were
treated by intraperitoneal delivery of 500μg α120G8 antibody or isotype control. Antibodies
were injected on d-1 before MCMV infection, followed by injections every 2 days. Mice were
infected with 2x104 pfu MCMV. Mortality was monitored daily. Data show the percent survival
from 1 experiment; n represents the number of mice per group.
(PDF)
S4 Fig. Impact of MyD88 deficiency on NK cell and IL-12 responses during MCMV infec-
tion. (A-C) Analysis of IFN-γ, Ki67 and Granzyme B expression in NK cells at d6 post
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infection. Data are shown for one representative mouse for each experimental group. Three in-
dependent experiments each with 3 mice per group were performed. (A) Splenic NK were
gated as TCRβ-CD19-NKp46+ cells, and split into Ly49H+ versus Ly49H- subsets in Ly49H-ex-
pressing mouse strains. (B-C) IFN-γ versus Ki67 (dot plots) and Granzyme B (histograms) ex-
pression at d6 post infection in Ly49H- (B) and Ly49H+ (C) NK cell subsets are shown for each
mouse strain. (D) Verification of the efficiency of NK cell depletion. The frequency of NK cells
is shown for one representative animal for each experimental group: in an uninfected and un-
treated animal, and at d6 after infection in one infected control mouse treated with rat IgG ver-
sus in one animal depleted of NK cells by in vivo administration of αNK1.1 antibodies. Three
independent experiments each with 2 to 3 mice per group were performed. (E) Splenic expres-
sion of the Il12b and Il18 genes at different time points after infection with 2.5x103 pfu MCMV
in BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c and BALB/c MyD88-/- mice, as mea-
sured in microarrays. (F) GSEA results for examining enrichment of the expression of IL-12/
IL-18 stimulated genes (n = 631) in pairwise comparisons between uninfected and infected ani-
mals at different time points after MCMV inoculation, in BALB/c-Ly49H+, BALB/c-Ly49H+
MyD88-/-, BALB/c and BALB/c MyD88-/- mice. The results are shown as described for S2E–
S2F Fig. (G) Heatmap showing the relative expression of selected IL-12/IL-18 stimulated genes.
For (E-G), the results shown are from the same microarray data as used in Fig 1D and 1E.
(PDF)
S5 Fig. Impact of MyD88 and Ly49H deficiencies on antiviral CD8 T cell responses and
spleen damages. (A) In vivo cytotoxic activity of antiviral CD8 T cells at d6 post-infection in
BALB/c-Ly49H+, BALB/c-Ly49H+ MyD88-/-, BALB/c and BALB/c MyD88-/- mice. Unpulsed
and IE-1 peptide-pulsed syngeneic splenocytes were stained with PKH26 and high versus low
concentrations of CFSE. These target cells were then transferred into mice at d6 post-MCMV
infection. The spleens were harvested 4h later to measure with PKH26+ transferred cells the
relative frequency between unpulsed (CSFEhigh) versus pulsed (CSFElow) targets in each mouse
and hence calculate the percent of specific in vivo killing by antiviral CD8 T cells. Data are
shown for one representative mouse for each experimental group. Three independent experi-
ments each with 2 or 3 mice per group were performed. (B) Verification of the efficiency of
CD8 T cell depletion and analysis of IFN-γ and Granzyme B expression in CD8 T cells. Data
are shown for one representative mouse for each experimental group. Two independent experi-
ments each with 2 to 4 mice per group were performed. Splenic CD8 T cells were gated as
NKp46-TCRβ+CD4-CD8α+ cells. In the upper row, the frequency of CD8 T cells is shown in
an uninfected and untreated animal, and at d6 after infection in one infected control mouse
treated with rat IgG versus in one animal depleted of CD8 T cells by in vivo administration of
αCD8β antibodies. In the lower row, the frequency of CD8 T cells expressing IFN-γ directly ex
vivo without any re-stimulation is shown in an uninfected animal, and at d6 after infection in
one infected animal for each of the four mouse strains studied, BALB/c-Ly49H+, BALB/c-
Ly49H+ MyD88-/-, BALB/c and BALB/c MyD88-/- mice. Granzyme B expression on CD8 T
cells is shown as histograms. (C) GSEA results for examining enrichment of the expression of
genes associated to “exhausted T cells” (n = 86) or “RPM” (n = 106), or of genes co-regulated
with COL6A1 (n = 95) or MMp19 (n = 98) in pairwise comparisons between Ly49H-/--
MyD88-/- mice and each of the 3 other mouse strains at d6 post infection. The results are
shown as described for S2E and S2F Fig. (D) Heatmaps showing the relative expression of se-
lected genes from the gene sets of panel C. For (C-D), the results shown are from the same mi-
croarray data as used in Fig 1D and 1E.
(PDF)
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S6 Fig. Anti-Bst2 antibody treatment promotes a selective but not entirely specific pDC de-
pletion after MCMV infection. (A) Splenocytes from BALB/c mice were stained and analyzed
by FACS at d0 or at d1.5 after infection with 2.5×103 pfu MCMV. Different cell populations
were selected (dot plots) and their Bst2 expression assessed by staining with 120G8 mAb (his-
tograms). Results are shown from one representative mouse of 3 for each condition. (B) Con-
trol (Rat IgG) or pDC-depleted (120G8 mAb treated) BALB/c mice were infected or not with
2.5 × 103 pfu MCMV. Splenocytes were stained and analyzed by FACS to assess the efficiency
and selectivity of the depletion. T+B (CD3ε+CD19+), NK (CD3ε-CD19-NKp46+), cDC
(CD3ε-CD19-NKp46-CD11chigh), pDC (CD3ε-CD19-NKp46-CD11cintSiglecH+) and other
cells («non NK-T-B-DC», CD3ε-CD19-CD11c-) were gated and their relative proportion indi-
cated on the dot plots. The absolute numbers of splenocytes did not differ between the 2 groups
of infected mice. Results are shown from one experiment representative of 3 independent ones,
each with 2 to 3 mice per group.
(PDF)
S1 Table. GeneSets used in bioinformatics analyses of microarray data.
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